Journals / Annals of Medical Research / 2021 / Cilt: 28 - Sayı: 8

Are noninvasive biochemical parameters an alternative toliver biopsy in patients with chronic hepatitis B?

Pages
1462–1466
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was a significant correlation between fibrosis level and age, liver function tests, bilirubin and albumin (p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: Although there is a gold standard liver biopsy in showing the histological activity of the disease, there are contradictory results in the studies conducted for using some non-invasive methods that are alternatively biochemically calculated due to being an invasive procedure.
📊
Key Findings & Data:We aimed to investigate the relationship of FIB-4, APRI, API and AAR values with histopathology in patients undergoing liver biopsy due to chronic hepatitis B virus (HBV) infection.
💡
Conclusion & Impact:There was a significant correlation between fibrosis level and age, liver function tests, bilirubin and albumin (p
🔬Design:Research Article
📍Scope:2016 Verileri
⚙️Variables:Domain Parameters

Abstract

Aim: Although there is a gold standard liver biopsy in showing the histological activity of the disease, there are contradictory results in the studies conducted for using some non-invasive methods that are alternatively biochemically calculated due to being an invasive procedure. We aimed to investigate the relationship of FIB-4, APRI, API and AAR values with histopathology in patients undergoing liver biopsy due to chronic hepatitis B virus (HBV) infection. Materials and Method: Patients with follow-up between November/2016-October/2019 with the diagnosis of chronic HBV were included. Demographic data and histopathological data were documented. Accompanying comorbid diseases, medications and previous operations were questioned. Patients were grouped as mild, moderate and advanced fibrosis according to fibrosis scoring. Sensitivity, specificity, cutt-of, AUC values of biochemical parameters were calculated between the groups. Results: A total of 151 patients, 64(42.3%) women, were included in the study. As a result of the liver biopsy; mild fibrosis was found in 73(48.3%) patients, moderate fibrosis in 33(21.8%) patients and advanced fibrosis in 45(29.9%) patients. There was a significant correlation between fibrosis level and age, liver function tests, bilirubin and albumin (p

🔖

Cite This Article

KONÜR, Ş., ÖZKAHRAMAN, A., KAYAR, Y., SÜRMELİ, N., DERTLİ, R. (2022). Are noninvasive biochemical parameters an alternative toliver biopsy in patients with chronic hepatitis B?. Annals of Medical Research, Cilt: 28 - Sayı: 8, 1462–1466. https://ajindex.com/articles/445847

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Akarca SU. Structure, Molecular Biology, Natural Mutants and Variants of Hepatitis B Virus. J Gastroenterohepatol Special Topics 2010;3:16-23
  2. Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virüs and hepatitis C virüs infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006;4:529-38
  3. Fattovich G, Brollo L, Giustina G, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut 1991;32:294-8
  4. Terrault NA, Bzowej NH, Chang KM, et al. American Association for the Study of Liver Diseases. AASLD guidelines for treatment of chronic hepatitis B. Hepatology 2016;63:261-83
  5. Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int 2016;10:1-98
  6. Seo YS, Kim MY, Kim SU, et al. Accuracy of transient elastography in assessing liver fibrosis in chronic viral hepatitis: a multicentre, retrospective study. Liver Int 2015;35:2246-55
  7. World Health Organization. Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015. Geneva, Switzerland; 2015. pp.15-8
  8. Kim DY, Kim SU, Ahn SH, et al. Usefulness of FibroScan for detection of early compensated liver cirrhosis in chronic hepatitis B. Dig Dis Sci 2009;54:1758-63
  9. Kekilli M, Tanoglu A, Sakin YS, et al. Is the neutrophil to lymphocyte ratio associated with liver fibrosis in patients with chronic hepatitis B? World J Gastroenterol 2015;21:5575-81
  10. Ozel Coskun BD, Dizdar OS, Baspinar O, et al. Usefulness of the Neutrophil-to-lymphocyte Ratio and Platelet Morphologic Parameters in Predicting Hepatic Fibrosis in Chronic Hepatitis C Patients Ann Clin Lab Sci 2016;46:4-8
  11. Wang J, Yan X, Yang Y, et al. A novel predictive model using routinely clinical parameters to predict liver fibrosis in patients with chronic hepatitis B. Oncotarget 2017;8:59257-67
  12. Sheeth SG, Flamm SL, Gordon FD, et al. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection. Am J Gastroenterol 1998;93:44-8
  13. Poynard T, Bedossa P. Age and platelet count: A simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups. J Viral Hepat 1997;4:199-208
  14. Chrysantos NV, Papatheodoritis GV, Savvas S, et al. Aspartate aminotrasferase to platelet ratio index for fibrosis evaluatio